Loading...
Please wait, while we are loading the content...
Similar Documents
Transitioning Between Biologics
| Content Provider | Semantic Scholar |
|---|---|
| Author | Frcpc, Ronald Vender Md |
| Copyright Year | 2019 |
| Abstract | Background : Transitioning between biologics has become an important part of practice. Objective : Patients with moderate to severe plaque psoriasis who are on biologics can have efficacy failures, as well as safety concerns. This would often necessitate a change of biologic, which may be within the same class or to a different class. A change due to an adverse event from the presently used biologic may resolve or require treatment until a new biologic is introduced, which may pose some delay in the initiation of the subsequent biologic. Methods : A review of the literature and guidelines published were performed. Results : A practical guide to transitioning between biologics are presented Limitations : There are no randomized placebo-controlled trials to determine the best method of transitioning between biologics. Conclusion : Transitioning between biologics is an option for those patients requiring such a change either for safety or efficacy reasons. |
| Starting Page | 374 |
| Ending Page | 380 |
| Page Count | 7 |
| File Format | PDF HTM / HTML |
| DOI | 10.25251/skin.3.6.2 |
| Volume Number | 3 |
| Alternate Webpage(s) | https://jofskin.org/index.php/skin/article/download/662/pdf_1 |
| Alternate Webpage(s) | https://doi.org/10.25251/skin.3.6.2 |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
